Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2008);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;11.171;Q1;193;23;70;3175;1539;70;21.51;138.04;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;10.461;Q1;210;20;83;6268;1506;75;17.46;313.40;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741776;7.292;Q1;289;170;654;7838;5186;325;15.15;46.11;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;22321;Trends in Pharmacological Sciences;journal;01656147;4.697;Q1;201;74;295;4592;2640;272;9.77;62.05;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
5;21195;Pharmacology and Therapeutics;journal;01637258;4.252;Q1;180;89;307;15071;2834;302;9.7;169.34;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
6;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;3.78;Q1;58;5;18;733;90;18;6.13;146.60;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
7;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.544;Q1;194;299;757;30468;4193;749;5.31;101.90;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
8;18017;Neuropsychopharmacology;journal;0893133X;3.385;Q1;204;321;789;19801;4903;742;6.45;61.69;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
9;4700152457;Nano Today;journal;17480132;3.37;Q1;119;21;65;977;289;38;7.61;46.52;Netherlands;Elsevier BV;2006-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
10;19409;Advanced Drug Delivery Reviews;journal;0169409X;3.144;Q1;278;129;363;13811;3239;304;9.15;107.06;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
11;18148;Pain;journal;03043959;3.03;Q1;238;393;939;15560;5242;752;6.26;39.59;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
12;20681;Current Opinion in Pharmacology;journal;14714892;3.008;Q1;120;110;307;5575;1882;268;6.87;50.68;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
13;26371;Natural Product Reports;journal;02650568, 14604752;2.918;Q1;157;58;171;8919;1025;160;5.97;153.78;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
14;12455;Molecular Therapy;journal;15250024, 15250016;2.837;Q1;158;254;742;9845;3771;668;5.61;38.76;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;12611;Drug Resistance Updates;journal;13687646, 15322084;2.826;Q1;100;16;61;2260;465;59;8.91;141.25;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
16;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.548;Q1;186;350;1224;13501;5552;1198;4.55;38.57;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
17;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.52;Q1;166;168;506;5701;1978;461;4.13;33.93;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.488;Q1;119;31;81;4526;604;80;8.37;146.00;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
19;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.45;Q1;232;713;2078;21621;9365;1948;4.83;30.32;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
20;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.379;Q1;127;140;379;6820;1672;353;4.08;48.71;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
21;29311;Current Cancer Drug Targets;journal;15680096;2.308;Q1;85;72;159;7181;731;150;4.47;99.74;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
22;21000196010;Topics in antiviral medicine;journal;21615853;2.302;Q1;37;19;53;220;132;52;1.55;11.58;United States;International Antiviral Society;2011-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
23;21782;Psychopharmacology;journal;00333158;2.275;Q1;181;339;1100;19532;4780;1052;4.45;57.62;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
24;23010;Journal of Controlled Release;journal;01683659;2.272;Q1;237;242;1057;10063;5376;1040;4.93;41.58;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
25;4400151524;Particle and Fibre Toxicology;journal;17438977;2.227;Q1;83;20;38;718;300;38;5.85;35.90;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
26;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.203;Q1;240;836;2446;35525;11893;2406;4.65;42.49;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
27;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.186;Q1;161;310;708;11903;3286;695;4.56;38.40;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
28;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;2.186;Q1;78;51;164;7211;766;145;5.04;141.39;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
29;20626;Clinical Pharmacology and Therapeutics;journal;00099236;2.176;Q1;173;254;541;6229;3118;449;6.29;24.52;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
30;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;2.166;Q1;89;97;212;3527;877;205;3.82;36.36;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1)"
31;5100155080;Neurotherapeutics;journal;19337213;2.162;Q1;100;48;188;3505;1045;171;4.77;73.02;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
32;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;2.095;Q1;98;45;95;5208;621;88;6.91;115.73;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
33;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;2.081;Q1;102;94;473;4890;1777;467;3.98;52.02;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
34;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.076;Q1;172;503;1273;11903;4870;1030;4.69;23.66;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
35;21196;Drug Discovery Today;journal;13596446;2.001;Q1;157;146;625;7795;2865;560;5.66;53.39;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
36;23916;Environmental Pollution;journal;02697491, 18736424;1.922;Q1;194;522;1130;21963;3911;1111;3.28;42.07;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
37;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.911;Q1;78;37;137;1597;804;131;5.61;43.16;United Kingdom;Nature Publishing Group;2001-ongoing;"Genetics (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
38;23488;Current Medicinal Chemistry;journal;09298673;1.9;Q1;158;239;661;32750;3368;646;4.8;137.03;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
39;26380;Drug and Alcohol Dependence;journal;03768716;1.874;Q1;151;257;636;11641;2393;617;3.59;45.30;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
40;20084;British Journal of Pharmacology;journal;00071188;1.856;Q1;190;525;1154;30047;4738;1122;4.38;57.23;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
41;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.855;Q1;209;454;1813;17323;7730;1785;4.34;38.16;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
42;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.843;Q1;93;98;236;5162;947;206;4.16;52.67;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
43;20435;Neuropharmacology;journal;00283908;1.797;Q1;150;241;743;13687;2555;737;3.3;56.79;United Kingdom;Elsevier Ltd.;1962-ongoing;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
44;20063;Biochemical Pharmacology;journal;00062952;1.768;Q1;181;356;1073;21244;4592;1004;5.03;59.67;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
45;25218;Toxicological Sciences;journal;10960929, 10966080;1.752;Q1;164;198;995;8909;4093;942;4.42;44.99;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
46;24749;Addiction Biology;journal;13556215, 13691600;1.72;Q1;70;42;114;2748;405;106;4.62;65.43;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
47;12331;Current Topics in Medicinal Chemistry;journal;15680266;1.705;Q1;104;158;408;11443;1551;349;4.22;72.42;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
48;4000148203;Handbook of Experimental Pharmacology;book series;01712004;1.701;Q1;81;122;299;12459;1067;286;3.45;102.12;Germany;Springer Verlag;2005-ongoing;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
49;21790;Antiviral Therapy;journal;13596535;1.698;Q1;78;105;394;3349;1352;379;3.36;31.90;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
50;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.659;Q1;82;81;130;8934;593;121;4.33;110.30;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1); Cancer Research (Q2)"
51;20682;Current Pharmaceutical Design;journal;13816128;1.642;Q1;140;310;966;35574;3973;860;4.65;114.75;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
52;20758;Current Drug Targets: Inflammation and Allergy;journal;1568010X;1.632;Q1;48;0;88;0;397;79;0;0.00;United Arab Emirates;Bentham Science Publishers;2002-2005;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2)"
53;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.629;Q1;143;225;790;10972;2463;771;3.03;48.76;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
54;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.628;Q1;81;56;208;1838;500;197;2.26;32.82;United Kingdom;Nature Publishing Group;2006-ongoing;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
55;20664;Current Drug Targets;journal;13894501;1.622;Q1;92;119;380;11015;1526;337;4.61;92.56;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
56;26512;Tetrahedron;journal;00404020;1.605;Q1;209;1219;3763;60373;11247;3700;2.93;49.53;United Kingdom;Elsevier Ltd.;1957-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
57;22072;Current Gene Therapy;journal;15665232;1.597;Q1;65;41;146;4914;613;140;3.95;119.85;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
58;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.561;Q1;89;23;111;2295;529;106;4.76;99.78;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
59;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.556;Q1;110;114;232;5549;1060;218;4.55;48.68;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
60;20104;CNS Drug Reviews;journal;1080563X, 15273458;1.552;Q1;52;0;57;0;219;56;4.38;0.00;United States;Neva Press, Inc.;1996-2007;"Neuropsychology and Physiological Psychology (Q1); Pharmacology (Q1)"
61;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.544;Q1;116;106;333;4392;846;316;2.49;41.43;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
62;21354;Expert Opinion on Therapeutic Targets;journal;14728222;1.533;Q1;78;111;302;11329;994;278;3.86;102.06;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
63;28792;Cancer Biology and Therapy;journal;15384047;1.512;Q1;101;399;1004;14269;2015;718;2.56;35.76;United States;Landes Bioscience;2002-ongoing;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
64;15576;European Neuropsychopharmacology;journal;0924977X;1.507;Q1;100;117;273;6132;1107;268;3.49;52.41;Netherlands;Elsevier BV;1990-ongoing;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
65;20624;Clinical Pharmacokinetics;journal;03125963;1.48;Q1;150;58;225;3666;1225;213;5.05;63.21;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
66;23109;Journal of Psychopharmacology;journal;02698811;1.428;Q1;106;151;362;5939;1301;307;3.99;39.33;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
67;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.41;Q1;191;314;695;13323;2767;682;4.29;42.43;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
68;16088;Journal of Nanobiotechnology;journal;14773155;1.4;Q1;57;11;31;343;132;29;4;31.18;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
69;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.395;Q1;161;303;823;10018;3357;805;3.87;33.06;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
70;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.394;Q1;75;74;205;4597;766;185;4.38;62.12;United Kingdom;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
71;144771;Clinical Trials;journal;17407753, 17407745;1.377;Q1;55;68;180;1576;311;160;1.63;23.18;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
72;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.365;Q1;144;258;630;14210;2283;607;3.57;55.08;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
73;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1.351;Q1;114;332;670;14224;2064;597;3.04;42.84;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
74;21455;Progress in Medicinal Chemistry;book series;00796468;1.35;Q1;33;5;21;946;61;18;2.36;189.20;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
75;26514;Tetrahedron Letters;journal;00404039;1.346;Q1;159;1682;5771;53569;14807;5692;2.55;31.85;United Kingdom;Elsevier Ltd.;1959-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
76;23053;Journal of Natural Products;journal;01633864, 15206025;1.343;Q1;124;367;1167;9126;3190;1137;2.92;24.87;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
77;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1.323;Q1;138;331;461;11697;1684;454;3.49;35.34;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
78;22477;Investigational New Drugs;journal;01676997, 15730646;1.323;Q1;80;68;208;1974;734;200;3.56;29.03;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
79;21197;Pharmacology Biochemistry and Behavior;journal;00913057;1.322;Q1;126;252;709;13607;2079;707;2.8;54.00;United States;Elsevier Inc.;1973-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
80;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.318;Q1;153;352;904;16911;3307;883;3.33;48.04;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
81;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;1.317;Q1;45;0;69;0;243;65;4.54;0.00;United States;Neva Press, Inc.;1988-2007;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
82;4000148019;AAPS Journal;journal;15507416;1.291;Q1;96;69;218;2919;853;208;4.58;42.30;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q1)
83;145164;Human Genomics;journal;14739542, 14797364;1.272;Q1;49;10;56;137;137;43;2.54;13.70;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
84;21165;PharmacoEconomics;journal;11707690;1.257;Q1;91;75;307;3288;798;257;2.69;43.84;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
85;21351;Expert Opinion on Investigational Drugs;journal;13543784;1.249;Q1;94;154;451;10572;1604;418;3.94;68.65;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
86;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.247;Q1;76;84;221;4587;597;218;2.61;54.61;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
87;22454;International Journal of Pharmaceutics;journal;03785173;1.227;Q1;190;620;1480;20482;4895;1460;3.16;33.04;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
88;21237;Drug Safety;journal;01145916;1.221;Q1;115;89;279;3789;986;242;3.74;42.57;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
89;29712;Clinical Therapeutics;journal;01492918;1.213;Q1;123;271;668;8039;2272;593;3.61;29.66;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
90;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.206;Q1;142;888;2150;32653;6348;2129;2.97;36.77;United Kingdom;Elsevier Ltd.;1993-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
91;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.204;Q1;70;18;53;3139;217;50;3.65;174.39;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
92;13250;Expert Opinion on Biological Therapy;journal;14712598;1.198;Q1;75;126;406;10965;1252;403;3.52;87.02;United Kingdom;Taylor & Francis;2001-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
93;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;1.195;Q1;69;13;38;2583;125;37;3.15;198.69;United States;Begell House;1984-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
94;19617;Antiviral Research;journal;01663542;1.194;Q1;108;123;306;5940;1050;301;3.34;48.29;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q2)"
95;21169;Pharmacological Research;journal;10436618, 10961186;1.191;Q1;118;104;406;5848;1396;400;3.58;56.23;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q1)
96;20663;Current Drug Metabolism;journal;13892002;1.182;Q1;97;114;174;11206;882;168;4.79;98.30;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
97;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.177;Q1;67;35;200;1844;486;197;2.36;52.69;Netherlands;Elsevier BV;1996, 1998-ongoing;"Pharmacology (Q1); Biochemistry (Q2); Cell Biology (Q2); Physiology (Q2)"
98;23155;Current Vascular Pharmacology;journal;15701611;1.168;Q1;54;37;104;3626;373;98;3.69;98.00;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
99;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.162;Q1;98;157;433;6367;830;431;1.86;40.55;Germany;Springer Verlag;1973-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
100;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.158;Q1;63;63;181;2660;395;151;2.63;42.22;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
101;14144;Experimental and Clinical Psychopharmacology;journal;10641297;1.157;Q1;82;56;142;3445;312;140;2.34;61.52;United States;American Psychological Association;1993-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
102;25075;Ecotoxicology;journal;09639292, 15733017;1.152;Q1;81;85;194;3984;455;190;2.34;46.87;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
103;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.152;Q1;87;118;388;4809;1293;382;3.17;40.75;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
104;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1.14;Q1;133;1249;3552;31459;9180;3509;2.57;25.19;United Kingdom;Elsevier Ltd.;1991-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
105;18071;Neurotoxicity Research;journal;10298428;1.136;Q1;65;53;147;4222;446;146;2.99;79.66;United States;Springer New York LLC;2001-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
106;20679;Current Opinion in Investigational Drugs;journal;14724472;1.135;Q1;71;126;375;8936;1036;341;3.54;70.92;United Kingdom;Current Drugs Ltd.;1994, 2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
107;18966;Mutagenesis;journal;02678357, 14643804;1.133;Q1;82;47;161;2820;447;152;2.97;60.00;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
108;19427;Advances in Pharmacology;book series;10543589;1.129;Q1;68;17;65;2561;142;59;3;150.65;United States;Elsevier Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
109;20051;BioDrugs;journal;11738804;1.121;Q1;60;38;110;3093;338;106;2.8;81.39;United Kingdom;Adis International Ltd.;1997-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Biotechnology (Q2)"
110;18800156720;Dissolution Technologies;journal;1521298X;1.121;Q1;28;16;73;220;70;40;1.36;13.75;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q1)
111;4600151527;Infectious Disorders - Drug Targets;journal;18715265;1.121;Q1;49;34;82;2979;236;76;3.49;87.62;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
112;24763;Addictive Behaviors;journal;03064603;1.118;Q1;114;171;694;5592;1511;691;2.02;32.70;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
113;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;1.107;Q1;79;130;339;12394;1042;329;3.12;95.34;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
114;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;1.1;Q1;62;0;67;0;172;63;0;0.00;United Kingdom;Blackwell Publishing Inc.;1991, 1993-2005;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
115;22983;Journal of Clinical Pharmacology;journal;00912700;1.093;Q2;106;123;456;3944;1582;436;3.49;32.07;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
116;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;1.085;Q2;42;35;53;3477;122;49;2.49;99.34;United Arab Emirates;Bentham Science Publishers;2006-2015;"Medicine (miscellaneous) (Q1); Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
117;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;1.083;Q1;114;458;1488;11943;4103;1465;2.8;26.08;Netherlands;Elsevier BV;1983-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Spectroscopy (Q2)"
118;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;1.081;Q1;100;243;602;7924;1637;590;2.73;32.61;Germany;Springer Verlag;1978-ongoing;"Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
119;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.073;Q2;131;259;655;6483;1768;523;3.36;25.03;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
120;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.069;Q1;60;58;229;3979;541;201;2.99;68.60;United Kingdom;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Genetics (Q2); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (clinical) (Q3); Molecular Biology (Q3)"
121;130025;Current Drug Delivery;journal;15672018;1.055;Q1;54;34;126;1900;374;124;2.7;55.88;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q1)
122;24028;Reproductive Toxicology;journal;08906238;1.048;Q1;99;113;357;4652;987;329;3.06;41.17;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q1)
123;4400151608;ChemMedChem;journal;18607187, 18607179;1.047;Q1;92;207;423;8812;1014;417;2.83;42.57;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2); Organic Chemistry (Q2)"
124;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;1.045;Q1;58;57;178;1592;552;174;2.79;27.93;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
125;15581;Current Pharmaceutical Biotechnology;journal;13892010;1.044;Q1;73;62;151;4851;385;133;2.88;78.24;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
126;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;1.044;Q2;74;221;528;7147;1312;510;2.61;32.34;Netherlands;Elsevier BV;1996-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
127;4700152612;Current Nanoscience;journal;15734137;1.043;Q1;37;51;74;3269;174;71;2.45;64.10;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Biotechnology (Q2); Nanoscience and Nanotechnology (Q2)"
128;16836;BMC Chemical Biology;journal;14726769;1.042;Q1;19;3;8;101;22;8;3;33.67;United Kingdom;BioMed Central;2001-2012;"Drug Discovery (Q1); Molecular Medicine (Q2)"
129;20783;Expert Review of Vaccines;journal;14760584;1.038;Q1;75;138;253;10660;649;227;2.95;77.25;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q1); Immunology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
130;19034;Microbial Drug Resistance;journal;10766294;1.038;Q2;62;44;149;1304;261;148;1.92;29.64;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Immunology (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2)"
131;5400152706;Nanotoxicology;journal;17435390, 17435404;1.034;Q1;72;25;26;1137;92;25;3.68;45.48;United Kingdom;Informa Healthcare;2007-ongoing;"Biomedical Engineering (Q1); Toxicology (Q1); Nanoscience and Nanotechnology (Q2)"
132;25789;Bioorganic Chemistry;journal;00452068, 10902120;1.028;Q2;50;41;107;1389;223;104;2;33.88;United States;Elsevier Inc.;1971-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
133;25109;Inhalation Toxicology;journal;08958378, 10917691;1.027;Q1;77;105;312;4035;701;294;2.4;38.43;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
134;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.025;Q1;106;39;125;1599;458;113;3.89;41.00;Netherlands;Elsevier BV;2005-ongoing;"Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
135;23015;Journal of Ethnopharmacology;journal;03788741;1.024;Q2;170;356;1266;13968;3484;1246;2.48;39.24;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
136;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;1.023;Q2;83;133;254;7718;622;245;2.76;58.03;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
137;21331;European Journal of Pharmaceutical Sciences;journal;09280987;1.022;Q1;119;108;532;3342;1517;523;3.8;30.94;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
138;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.02;Q1;89;116;301;4114;699;284;2.26;35.47;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
139;25240;Toxicology Letters;journal;03784274;1.02;Q1;129;195;606;7467;1837;585;3.14;38.29;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
140;21333;European Journal of Pharmacology;journal;00142999;1.018;Q2;167;795;2086;35671;5743;2069;2.86;44.87;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q2)
141;25219;Toxicology;journal;0300483X;1.01;Q2;143;264;938;12097;2725;914;2.87;45.82;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q2)
142;23014;Journal of Drug Targeting;journal;10292330, 1061186X;1.008;Q1;80;82;221;3038;543;204;2.78;37.05;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
143;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.007;Q2;33;31;93;434;92;77;1.31;14.00;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2); Statistics and Probability (Q2)"
144;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;1.004;Q2;99;104;362;5363;924;361;2.51;51.57;Netherlands;Elsevier BV;2000-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Physiology (Q2); Toxicology (Q2); Cell Biology (Q3)"
145;17595;Journal of Biomolecular Screening;journal;10870571;1;Q2;69;85;286;2038;732;281;2.5;23.98;United States;Sage Science Press;1996-ongoing;"Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
146;23079;Journal of Pharmaceutical Sciences;journal;00223549;0.995;Q1;159;370;759;18735;2390;700;3.28;50.64;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
147;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.993;Q2;54;33;104;917;217;99;2.39;27.79;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q2)
148;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.992;Q2;91;138;504;5739;1085;495;2.3;41.59;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
149;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.989;Q2;89;70;166;2855;532;162;3.43;40.79;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q1); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
150;21167;Pharmacogenomics;journal;14622416;0.988;Q2;83;182;356;9640;1098;313;3.65;52.97;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
151;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.986;Q2;43;31;131;3751;352;131;2.81;121.00;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
152;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.973;Q2;88;117;437;4401;1121;433;2.47;37.62;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
153;17464;European Journal of Medicinal Chemistry;journal;02235234;0.962;Q2;135;285;497;9421;1405;491;2.67;33.06;Netherlands;Elsevier BV;1974-ongoing;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
154;24652;Chemico-Biological Interactions;journal;00092797;0.961;Q2;108;141;481;6296;1332;472;3.28;44.65;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
155;18075;Neurotoxicology and Teratology;journal;08920362;0.958;Q2;89;38;222;2520;582;209;2.64;66.32;Netherlands;Elsevier BV;1987-ongoing;"Toxicology (Q2); Cellular and Molecular Neuroscience (Q3); Developmental Neuroscience (Q3)"
156;22378;Vascular Pharmacology;journal;15371891;0.957;Q2;86;47;291;2300;745;282;2.65;48.94;Netherlands;Elsevier BV;2002-ongoing;"Pharmacology (Q2); Physiology (Q2); Molecular Medicine (Q3)"
157;18073;NeuroToxicology;journal;0161813X;0.955;Q2;102;128;378;6819;933;353;2.34;53.27;Netherlands;Elsevier BV;1979-ongoing;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
158;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.952;Q2;72;124;187;10962;691;181;3.49;88.40;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
159;20473;Life Sciences;journal;00243205;0.949;Q1;150;265;1700;10895;4519;1692;2.68;41.11;Netherlands;Elsevier BV;1962-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2)"
160;84948;Expert Opinion on Drug Delivery;journal;17425247;0.942;Q1;88;87;189;8707;547;174;3.37;100.08;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
161;22575;Cardiovascular Toxicology;journal;15307905;0.938;Q2;47;21;88;937;172;88;2.05;44.62;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Toxicology (Q2); Molecular Biology (Q3)"
162;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;0.938;Q1;110;180;43;7400;102;37;2.76;41.11;United States;Public Library of Science;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Infectious Diseases (Q2)"
163;16948;Chirality;journal;1520636X, 08990042;0.936;Q2;73;122;336;4493;691;324;1.98;36.83;United States;John Wiley & Sons Inc.;1989-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
164;19900192900;Molecular Informatics;journal;18681751, 18681743;0.925;Q2;60;100;268;4285;600;255;2.34;42.85;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
165;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.909;Q2;64;49;212;2012;523;203;2.45;41.06;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
166;24785;Alcohol;journal;07418329;0.905;Q2;74;64;181;2970;452;172;2.44;46.41;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
167;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.904;Q2;77;75;409;2571;691;399;1.74;34.28;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
168;22319;Toxicon;journal;00410101;0.898;Q2;116;290;690;10135;1817;668;2.65;34.95;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q2)
169;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.886;Q2;95;223;557;8646;1261;543;2.51;38.77;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
170;17067;Phytomedicine;journal;09447113;0.884;Q1;105;145;371;4172;980;357;2.68;28.77;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
171;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;0.863;Q2;64;34;87;1507;200;83;2.41;44.32;Germany;Springer Verlag;2006-ongoing;"Immunology and Allergy (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
172;20602;Clinical Neuropharmacology;journal;03625664;0.859;Q2;74;59;190;1455;560;171;2.86;24.66;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Pharmacology (medical) (Q1); Neurology (clinical) (Q2); Pharmacology (Q2)"
173;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.852;Q2;99;149;523;5154;1249;460;2.57;34.59;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
174;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0.831;Q2;80;158;496;6127;904;488;1.72;38.78;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
175;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.826;Q2;79;246;748;7026;1239;739;1.52;28.56;United States;Wiley-Blackwell;1918-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3)"
176;23039;Journal of Liposome Research;journal;08982104, 15322394;0.817;Q1;44;24;72;901;147;71;2.07;37.54;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q1)
177;4400151410;Human Vaccines;journal;15548600, 15548619;0.811;Q1;49;63;126;2751;254;113;2.28;43.67;United States;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q3)"
178;14805;Steroids;journal;0039128X;0.81;Q2;95;169;367;6844;935;366;2.52;40.50;Netherlands;Elsevier BV;1963-ongoing;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
179;25125;Journal of Analytical Toxicology;journal;01464760;0.802;Q2;69;111;324;2445;532;305;1.63;22.03;United States;Perston Publications, Inc.;1977-ongoing;"Chemical Health and Safety (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
180;25224;Toxicology in Vitro;journal;08872333;0.796;Q2;96;238;509;8987;1367;500;2.7;37.76;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
181;24604;Archives of Toxicology;journal;14320738, 03405761;0.794;Q2;96;99;272;4711;664;261;2.64;47.59;Germany;Springer Verlag;1972-ongoing;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
182;25093;Environmental Toxicology;journal;15227278, 15204081;0.792;Q2;69;85;216;2955;454;213;1.96;34.76;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
183;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;0.792;Q1;61;36;139;1481;291;121;2.18;41.14;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
184;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.79;Q2;43;83;207;1486;201;184;1.01;17.90;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
185;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.786;Q2;37;31;103;3183;254;97;2.35;102.68;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
186;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.782;Q2;90;1;487;0;1297;475;2.17;0.00;United Kingdom;Taylor & Francis;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
187;22432;International Immunopharmacology;journal;15675769;0.782;Q2;98;237;616;8553;1438;596;2.43;36.09;Netherlands;Elsevier BV;2001-ongoing;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
188;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.773;Q2;78;93;268;3348;516;256;1.78;36.00;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
189;25096;Food and Chemical Toxicology;journal;02786915;0.771;Q2;149;608;757;23166;1900;741;2.37;38.10;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
190;20634;Journal of Texture Studies;journal;00224901;0.769;Q1;48;38;115;1230;153;109;1.3;32.37;United States;Wiley-Blackwell;1969-ongoing;"Food Science (Q1); Pharmaceutical Science (Q1)"
191;130063;Pharmacological Reports;journal;17341140, 22995684;0.769;Q2;71;114;363;5165;804;360;2;45.31;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
192;4000150314;Chemical Biology and Drug Design;journal;17470277;0.766;-;71;111;346;3985;600;326;2.29;35.90;United Kingdom;Blackwell;2006-ongoing;"Biochemistry (Q3); Molecular Medicine (Q3)"
193;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.764;Q2;90;151;267;6500;614;246;2.41;43.05;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
194;19984;Assay and Drug Development Technologies;journal;1540658X;0.759;Q2;52;121;216;1523;377;160;2.24;12.59;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3)"
195;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0.755;Q2;36;28;56;1027;118;55;2.08;36.68;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
196;4700152848;PPAR Research;journal;16874757, 16874765;0.747;Q2;40;96;53;7860;113;48;2.35;81.88;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Drug Discovery (Q2); Pharmacology (medical) (Q2)"
197;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.745;Q1;104;410;1376;12461;2693;1364;1.91;30.39;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
198;23942;Biomedical Chromatography;journal;10990801, 02693879;0.743;Q2;58;188;461;4463;801;456;1.73;23.74;United States;John Wiley & Sons Inc.;1986-ongoing;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
199;25214;Toxicologic Pathology;journal;15331601, 01926233;0.739;Q2;96;105;313;3516;667;290;1.96;33.49;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
200;21865;Fundamental and Clinical Pharmacology;journal;07673981;0.732;Q2;64;68;224;3033;512;215;2.18;44.60;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
201;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.73;Q2;36;35;102;4756;196;102;1.94;135.89;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2)"
202;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.714;Q2;78;100;369;3546;826;359;2.44;35.46;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
203;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;0.71;Q2;61;35;99;1412;195;95;2.13;40.34;United States;Mary Ann Liebert Inc.;2011-ongoing;"Drug Discovery (Q2); Biochemistry (Q3); Genetics (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
204;15840;Journal of Antibiotics;journal;00218820;0.709;Q2;73;97;323;1773;396;294;1.2;18.28;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
205;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.707;Q2;87;122;400;3583;915;366;2.54;29.37;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
206;20027;BMC Pharmacology;journal;14712210;0.705;Q2;38;19;47;693;95;46;1.79;36.47;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
207;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.704;Q2;34;38;85;2967;192;81;2.37;78.08;United Kingdom;Adis International Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
208;22318;Toxicological Reviews;journal;11762551;0.686;Q2;42;0;45;0;148;38;3.63;0.00;United Kingdom;Adis International Ltd.;2003-2006;"Pharmacology (Q2); Toxicology (Q2)"
209;25898;Journal of Peptide Science;journal;10752617, 10991387;0.685;Q2;60;128;318;5182;520;305;1.53;40.48;United States;John Wiley & Sons Inc.;1995-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
210;29053;Molecular Diversity;journal;1573501X, 13811991;0.683;Q2;54;16;118;587;290;113;2.92;36.69;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Biology (Q3); Catalysis (Q4)"
211;21744;Planta Medica;journal;14390221, 00320943;0.683;Q1;103;204;732;5506;1345;703;1.73;26.99;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
212;21687;American Journal of PharmacoGenomics;journal;11752203;0.682;Q2;36;0;37;0;88;36;0;0.00;United Kingdom;Adis International Ltd.;2001-2005;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
213;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.678;Q2;54;41;97;2051;164;87;2.05;50.02;United States;John Wiley & Sons Inc.;2003-ongoing;"Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
214;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.674;Q2;56;37;107;1387;243;105;2.2;37.49;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
215;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0.671;Q2;46;14;96;762;178;93;1.77;54.43;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
216;24578;Mathematical Medicine and Biology;journal;14778599;0.669;Q2;40;20;54;656;108;53;1.65;32.80;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Environmental Science (miscellaneous) (Q1); Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)"
217;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.664;Q2;84;337;1067;8154;1743;1061;1.63;24.20;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
218;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.663;Q2;78;178;677;6285;1178;666;1.68;35.31;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
219;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0.651;Q2;53;66;188;2134;300;185;1.5;32.33;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
220;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0.65;Q2;80;149;405;5778;804;396;1.98;38.78;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
221;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.649;Q2;70;242;480;8490;911;477;1.85;35.08;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
222;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.647;Q2;68;45;129;1508;266;119;2.37;33.51;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
223;19374;AAPS PharmSciTech;journal;15221059, 15309932;0.643;Q1;79;168;285;4515;532;273;1.43;26.88;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Pharmaceutical Science (Q1); Agronomy and Crop Science (Q2); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
224;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;0.641;Q2;44;28;113;1442;191;105;1.73;51.50;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
225;16573;Phytotherapy Research;journal;10991573, 0951418X;0.641;Q2;112;281;647;8329;1292;639;1.89;29.64;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q2)
226;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.636;Q2;70;52;206;1571;320;205;1.21;30.21;United Kingdom;Taylor & Francis;1984-ongoing;"Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2)"
227;4700152603;Medicinal Chemistry;journal;15734064;0.632;Q2;39;75;193;2780;392;193;1.93;37.07;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q2)
228;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.631;Q2;54;73;226;2193;320;216;1.35;30.04;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
229;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.628;Q2;42;36;121;1054;254;118;2.12;29.28;United Kingdom;Taylor & Francis;1993-ongoing;"Bioengineering (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
230;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.627;Q2;36;23;47;2218;102;47;2.17;96.43;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
231;21256;Drugs of Today;journal;16993993, 16994019;0.618;Q2;46;101;215;4958;419;212;1.82;49.09;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
232;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.608;Q2;69;41;160;1841;366;159;1.69;44.90;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
233;23412;Journal of AOAC International;journal;10603271;0.606;Q2;79;154;654;3897;1011;645;1.31;25.31;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
234;20770;Drug Delivery;journal;10717544;0.602;Q2;52;54;164;1539;297;163;1.53;28.50;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
235;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0.602;Q2;107;200;600;8098;1118;593;1.85;40.49;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
236;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;0.6;Q2;55;91;326;2464;366;225;1.72;27.08;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Pharmacy (Q1); Health Policy (Q2); Pharmaceutical Science (Q2)"
237;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.598;Q2;78;165;366;4918;501;360;1.13;29.81;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
238;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0.595;Q2;69;273;742;20081;1487;709;2.24;73.56;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
239;19443;American Journal of Health-System Pharmacy;journal;10792082;0.594;Q2;87;426;1252;6614;1333;826;1.49;15.53;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
240;20570;Chemotherapy;journal;00093157, 14219794;0.592;Q2;49;54;219;1530;369;213;1.61;28.33;Switzerland;S. Karger AG;1963-ongoing;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
241;21229;Drug News and Perspectives;journal;02140934;0.592;Q2;47;62;233;3052;299;231;1.18;49.23;Spain;J.R. Prous;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
242;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.588;Q2;55;86;280;2527;481;257;1.5;29.38;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
243;7700153108;International journal of nanomedicine;journal;11782013, 11769114;0.58;Q2;100;52;105;2391;190;100;1.9;45.98;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Bioengineering (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Biomaterials (Q3); Biophysics (Q3); Nanoscience and Nanotechnology (Q3); Organic Chemistry (Q3)"
244;16533;Phytochemical Analysis;journal;09580344, 10991565;0.579;Q2;63;74;195;1671;339;194;1.6;22.58;United States;John Wiley & Sons Inc.;1990-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Food Science (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Molecular Medicine (Q3)"
245;4000148406;Clinical Toxicology;journal;15563650;0.575;Q2;85;207;321;3955;499;269;1.78;19.11;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
246;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.574;Q2;76;106;217;4686;400;212;2.08;44.21;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q2)
247;20026;BMC Clinical Pharmacology;journal;14726904;0.571;Q2;35;12;27;350;77;27;1.95;29.17;United Kingdom;BioMed Central;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
248;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.571;Q2;53;47;137;1912;211;130;1.82;40.68;United States;John Wiley & Sons Inc.;1998-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Molecular Biology (Q4)"
249;22410;Inflammation Research;journal;1420908X, 10233830;0.57;Q2;82;122;342;3455;521;339;1.41;28.32;Switzerland;Birkhauser Verlag;1995-ongoing;"Pharmacology (Q2); Immunology (Q3)"
250;25864;Heterocycles;journal;03855414;0.563;Q2;61;288;1147;9344;1266;1136;1.06;32.44;Netherlands;Elsevier BV;1983, 1985-ongoing;"Pharmacology (Q2); Analytical Chemistry (Q3); Organic Chemistry (Q3)"
251;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0.561;Q2;59;83;255;5337;516;231;1.93;64.30;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q3)"
252;16319;IEEE Transactions on Nanobioscience;journal;15361241;0.558;Q2;55;33;113;1037;239;106;1.53;31.42;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
253;18077;Fitoterapia;journal;0367326X;0.556;Q2;90;114;431;1895;669;429;1.36;16.62;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
254;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.552;Q2;54;82;230;2624;362;226;1.3;32.00;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
255;20580;Journal of Food Biochemistry;journal;01458884;0.542;Q2;40;50;133;1734;128;132;0.69;34.68;United States;Wiley-Blackwell;1977-ongoing;"Food Science (Q2); Pharmacology (Q2); Biophysics (Q3); Cell Biology (Q3)"
256;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.542;Q1;19;12;38;351;58;37;1.84;29.25;United Kingdom;BioMed Central;2002-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
257;14822;Xenobiotica;journal;00498254, 13665928;0.535;Q3;75;86;226;4709;478;225;2.12;54.76;United Kingdom;Taylor & Francis;1971-ongoing;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
258;4700152769;Pharmacopeial Forum;journal;03634655;0.531;Q3;16;17;64;169;22;31;0.89;9.94;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Pharmacy (Q1); Drug Guides (Q2); Pharmacology (Q3)"
259;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.528;Q2;50;58;170;1434;203;167;1.09;24.72;United States;Marcel Dekker Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
260;16067;Reading Teacher;journal;00340561;0.526;Q3;44;81;214;1727;105;211;0.45;21.32;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (medical) (Q2); Pharmacology (Q3)"
261;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.524;Q3;72;118;374;4125;490;371;1.16;34.96;Netherlands;Elsevier BV;1996-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
262;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.519;Q3;65;97;251;2389;408;224;1.93;24.63;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
263;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.515;Q3;30;50;123;1459;133;120;1.1;29.18;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
264;13248;Experimental and Toxicologic Pathology;journal;09402993;0.508;Q3;58;81;180;2478;311;177;1.36;30.59;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q3); Cell Biology (Q4)"
265;21353;Expert Opinion on Therapeutic Patents;journal;13543776;0.505;Q3;61;97;321;8026;353;310;1.11;82.74;United Kingdom;Taylor & Francis;1991-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
266;25106;Human and Experimental Toxicology;journal;09603271;0.504;Q3;71;127;298;3866;459;276;1.49;30.44;United States;SAGE Publications;1981-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
267;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0.503;Q3;55;82;225;2807;342;213;1.33;34.23;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3); Pharmacology (Q3)"
268;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.492;Q3;29;23;47;2346;72;47;1.53;102.00;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Drug Discovery (Q3)"
269;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.487;Q2;54;56;135;1535;215;135;1.86;27.41;United States;John Wiley & Sons Inc.;1979-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
270;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0.487;Q1;79;178;605;5272;885;597;1.35;29.62;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
271;13671;Biologicals;journal;10958320, 10451056;0.481;Q3;51;55;153;1482;159;136;1.17;26.95;United States;Elsevier Inc.;1990-ongoing;"Medicine (miscellaneous) (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
272;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.48;Q2;46;213;648;5474;729;639;1.04;25.70;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
273;21194;Pharmacology;journal;00317012, 14230313;0.479;Q3;54;75;225;2782;341;224;1.82;37.09;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
274;22456;International Journal of Pharmacy Practice;journal;09617671;0.472;Q2;32;49;112;1310;62;103;0.62;26.73;United Kingdom;Wiley-Blackwell;1991-ongoing;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q2)"
275;14990;Current Neuropharmacology;journal;1570159X;0.467;Q3;58;26;78;5205;72;74;1.04;200.19;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (Q3)"
276;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.459;Q3;62;80;267;1893;410;244;1.56;23.66;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
277;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.458;Q3;61;124;261;3760;372;256;1.43;30.32;United Kingdom;Taylor & Francis;1985-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
278;21264;Drugs in R and D;journal;11745886;0.455;Q3;39;43;122;2273;212;121;1.99;52.86;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q3)
279;110172;Progress in Drug Research;book series;0071786X;0.453;Q1;38;20;36;2384;57;33;3.08;119.20;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
280;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.449;Q3;55;87;218;2454;346;187;1.61;28.21;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Medical Laboratory Technology (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
281;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.441;Q3;43;23;96;1114;171;94;1.97;48.43;United States;Begell House;1984-1990, 1992-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
282;26370;Molecules;journal;14203049;0.441;Q2;116;227;449;8211;538;429;1.23;36.17;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
283;130047;Current Drug Discovery Technologies;journal;15701638;0.438;Q3;38;39;68;2701;122;65;1.64;69.26;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q3)
284;144790;Marine Drugs;journal;16603397;0.438;Q3;84;31;45;2371;61;44;1.36;76.48;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q3)
285;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.436;Q3;30;24;61;745;69;61;0.88;31.04;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Physiology (Q3)"
286;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.432;Q3;62;66;190;2257;266;188;1.48;34.20;United States;Wiley-Blackwell;1986-ongoing;"Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
287;21207;Drug Discovery Today: Technologies;journal;17406749;0.429;Q3;41;13;136;479;163;123;0.92;36.85;Netherlands;Elsevier BV;2004-ongoing;"Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
288;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.426;Q2;35;56;131;851;148;126;1.03;15.20;United States;Informa Healthcare;2013-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
289;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.425;Q3;51;61;184;3026;246;174;1.52;49.61;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
290;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.421;Q3;63;230;862;4180;572;854;0.6;18.17;Germany;Springer Verlag;1966-ongoing;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
291;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.421;Q3;58;121;333;1973;243;305;0.78;16.31;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
292;23489;Chemical Speciation and Bioavailability;journal;09542299;0.42;Q3;25;23;49;801;44;47;0.74;34.83;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
293;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.42;Q2;22;27;60;2132;64;60;1.07;78.96;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q3)"
294;19958;Archives of Pharmacal Research;journal;02536269;0.419;Q3;75;228;591;6060;751;590;1.14;26.58;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4)"
295;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.416;Q3;40;161;409;4665;407;401;1.11;28.98;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
296;27210;In Vivo;journal;0258851X;0.415;Q3;54;125;394;3543;462;384;0.99;28.34;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
297;21192;Drug Development Research;journal;02724391, 10982299;0.413;Q3;54;54;231;3035;272;218;1.38;56.20;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q3)
298;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.413;Q3;33;40;41;1597;81;41;1.98;39.93;United Kingdom;BioMed Central;2006-ongoing;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
299;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.412;Q3;38;34;94;1015;107;93;1.23;29.85;United States;Marcel Dekker Inc.;1977-ongoing;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
300;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.412;Q3;45;123;334;3079;553;323;1.91;25.03;Italy;SAGE Publications Inc.;1989-ongoing;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
301;21211;Pharmacy Education;journal;14772701, 15602214;0.409;Q2;15;9;113;142;41;112;0.29;15.78;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmacy (Q1); Education (Q2); Pharmaceutical Science (Q2)"
302;22411;Inflammopharmacology;journal;09254692, 15685608;0.408;Q3;45;41;147;1893;180;142;1.2;46.17;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (medical) (Q2); Immunology (Q3); Pharmacology (Q3)"
303;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.406;Q3;18;7;26;289;29;25;1;41.29;United Kingdom;BioMed Central;2003-2011;"Immunology (Q3); Pharmacology (Q3)"
304;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.392;Q3;44;72;119;1803;143;118;1.2;25.04;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
305;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.391;Q3;47;77;215;2831;253;214;1.06;36.77;Spain;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
306;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.388;Q2;35;205;297;2227;241;296;0.69;10.86;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
307;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0.382;Q3;30;10;108;359;85;106;0.82;35.90;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q3)
308;19441;American Journal of Drug Delivery;journal;11759038;0.375;Q3;19;0;49;0;52;43;1.54;0.00;United Kingdom;Adis International Ltd.;2004-2006;Pharmacology (Q3)
309;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.373;Q2;52;95;226;2352;221;205;1.04;24.76;Germany;Springer Verlag;2010-ongoing;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacy (Q2); Pharmacology (Q3); Toxicology (Q3)"
310;11700154733;Journal of Biomedical Nanotechnology;journal;15507033;0.37;Q2;64;56;48;2993;34;45;0.76;53.45;United States;American Scientific Publishers;2007-ongoing;"Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Nanoscience and Nanotechnology (Q4)"
311;6400153120;Chinese Medicine;journal;17498546;0.366;Q3;34;16;16;760;39;15;2.6;47.50;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmacology (Q3)"
312;21717;Die Pharmazie;journal;00317144;0.362;Q2;56;136;626;3176;610;620;0.92;23.35;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
313;10900153328;Frontiers in Drug Design and Discovery;book series;15672042;0.362;Q2;8;0;41;0;26;39;0.67;0.00;United Arab Emirates;Bentham Science Publishers;2006-2009;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
314;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.361;Q3;24;30;44;2612;44;40;1.1;87.07;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
315;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.36;Q1;52;141;375;1934;232;352;0.68;13.72;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
316;23009;Journal of Clinical Research;journal;13695207;0.359;Q3;11;2;7;84;13;7;0.33;42.00;United Kingdom;Brookwood Medical Publications Ltd;1998-2009;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
317;25144;Journal of Health Science;journal;13475207, 13449702;0.357;Q3;42;104;356;2973;300;355;0.69;28.59;Kenya;African Forum for Health Sciences;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
318;15340;Developments in Biologicals;book series;14246074;0.356;Q3;35;122;318;1574;262;313;0.71;12.90;Switzerland;S. Karger AG;2000-2008, 2010-2013;"Immunology (Q3); Pharmacology (Q3); Biomaterials (Q4)"
319;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;0.351;Q3;38;8;24;1070;28;23;1.22;133.75;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Toxicology (Q3); Cancer Research (Q4)"
320;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.348;Q3;21;25;74;2377;64;69;0.85;95.08;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Infectious Diseases (Q3); Pharmacology (Q3)"
321;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.348;Q3;42;70;154;2384;146;151;0.88;34.06;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3); Immunology (Q4)"
322;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.346;Q3;26;36;181;1747;134;163;0.83;48.53;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
323;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0.336;Q3;27;22;50;1985;60;50;1.2;90.23;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3)"
324;21262;Drugs under Experimental and Clinical Research;journal;03786501;0.335;Q3;37;0;36;0;53;36;0;0.00;Switzerland;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
325;29947;Journal of Chemotherapy;journal;1120009X;0.334;Q3;45;112;386;3352;324;349;0.68;29.93;United Kingdom;Maney Publishing;1989-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
326;19398;Acta Pharmaceutica;journal;13300075;0.332;Q2;49;40;105;739;146;103;1.11;18.48;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
327;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.332;Q2;37;36;92;1257;65;84;0.64;34.92;Netherlands;Elsevier BV;2005-ongoing;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
328;5400152628;Brazilian Journal of Pharmacognosy;journal;0102695X, 1981528X;0.328;Q2;37;105;93;3713;211;89;2.37;35.36;Brazil;Sociedade Brasileira de Farmacognosia;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
329;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0.319;Q3;50;106;196;9775;175;192;0.91;92.22;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery (Q3)
330;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0.313;Q2;38;54;196;1808;111;192;0.39;33.48;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q2)
331;19700185200;Journal of Natural Medicines;journal;18610293;0.31;Q2;37;94;147;2097;106;145;0.92;22.31;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Organic Chemistry (Q3)"
332;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0.305;Q3;34;30;102;655;79;96;0.74;21.83;France;Springer Paris;1976-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
333;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.304;Q2;50;190;563;3439;300;556;0.6;18.10;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
334;130038;Letters in Drug Design and Discovery;journal;15701808;0.302;Q2;28;73;296;1703;192;294;0.67;23.33;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
335;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.3;Q3;58;28;124;868;68;102;0.53;31.00;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
336;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0.296;Q2;43;132;733;3360;392;729;0.45;25.45;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
337;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.293;Q2;53;101;381;3371;254;378;0.6;33.38;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
338;5800173383;Current Clinical Pharmacology;journal;15748847;0.289;Q2;33;24;40;1878;33;40;0.83;78.25;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
339;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.283;Q2;53;48;121;1507;101;118;0.83;31.40;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Pharmaceutical Science (Q2); Aging (Q3); Chemistry (miscellaneous) (Q3); Colloid and Surface Chemistry (Q3); Dermatology (Q3); Drug Discovery (Q3)"
340;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0.283;Q2;33;44;127;1429;82;113;0.65;32.48;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
341;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.282;Q3;30;18;51;284;17;48;0.41;15.78;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
342;21265;Drugs of the Future;journal;03778282;0.281;Q3;40;123;836;6826;191;321;0.58;55.50;Spain;Prous Science;1978-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
343;19383;Fluoride - Quarterly Reports;journal;00154725;0.28;Q3;41;59;140;953;132;122;1.1;16.15;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Biochemistry (Q4)"
344;17700155034;Natural product communications;journal;15559475, 1934578X;0.28;Q3;35;340;332;9765;227;321;0.71;28.72;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
345;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0.279;Q2;29;190;661;3540;323;661;0.43;18.63;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
346;21758;Prescrire International;journal;11677422;0.278;Q3;11;224;373;1762;119;311;0.35;7.87;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
347;110097;Food and Drug Law Journal;journal;1064590X;0.275;Q3;18;43;105;6119;29;104;0.24;142.30;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
348;22375;Indian Drugs;journal;0019462X;0.273;Q2;30;148;455;2607;114;454;0.23;17.61;India;Scientific Publishers;1989-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
349;19978;Ars Pharmaceutica;journal;00042927, 23409894;0.27;Q2;18;36;80;775;39;80;0.49;21.53;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q2); Pharmaceutical Science (Q2)"
350;21100470510;Drug Research;journal;21949379, 21949387;0.27;Q3;56;128;340;2457;240;333;0.66;19.20;Germany;Thieme;1972, 2013-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
351;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;0.267;Q2;9;0;58;0;36;58;0.68;0.00;United Kingdom;Blackwell Publishing Inc.;2005-2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
352;4700152607;Current Enzyme Inhibition;journal;15734080;0.267;Q3;15;20;54;1890;39;54;0.72;94.50;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
353;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0.266;Q2;29;0;25;0;38;25;0;0.00;Switzerland;Bioscience Ediprint Inc.;1981-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
354;21102;Pharmaceutical Journal;journal;00316873;0.265;Q2;25;1048;4600;985;127;617;0.18;0.94;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
355;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.264;Q3;52;79;295;1588;190;223;0.71;20.10;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
356;26767;Altex;journal;1868596X, 18688551;0.263;Q3;45;37;123;813;109;117;0.9;21.97;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
357;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.261;Q3;52;53;133;2690;96;130;0.69;50.75;United States;SAGE Publications;1985-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
358;5800173394;Current Drug Therapy;journal;15748855;0.259;Q2;14;20;30;2194;20;28;0.71;109.70;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
359;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.255;Q3;41;82;409;1617;240;404;0.55;19.72;United States;John Wiley & Sons Inc.;1976-ongoing;"Drug Discovery (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Analytical Chemistry (Q4); Biochemistry (Q4); Organic Chemistry (Q4); Spectroscopy (Q4)"
360;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0.255;Q3;18;90;188;489;72;178;0.45;5.43;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
361;20065;BioPharm International;journal;1542166X;0.254;Q2;25;109;410;615;108;347;0.37;5.64;United States;UBM Medica Periodical Publication;2002-ongoing;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
362;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.253;Q3;33;36;73;5869;39;67;0.59;163.03;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q4)"
363;4500151530;Personalized Medicine;journal;17410541;0.252;Q3;24;74;94;2315;57;81;0.7;31.28;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
364;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.251;Q3;18;55;50;1887;34;43;1.15;34.31;Finland;Nordic Association of Occupational Safety and Health (NOROSH);2005-2011, 2016-ongoing;"Geography, Planning and Development (Q2); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
365;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0.248;Q3;27;98;292;1655;129;290;0.44;16.89;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
366;20578;Journal of Food and Drug Analysis;journal;10219498;0.248;Q3;41;69;189;2011;102;180;0.48;29.14;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q3); Pharmacology (Q3)"
367;11500153306;Recent Patents on Drug Delivery and Formulation;journal;18722113;0.246;Q2;25;16;21;1827;16;21;0.76;114.19;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
368;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.242;Q2;45;128;317;3294;313;312;1.04;25.73;China;Zhejiang University Press;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Veterinary (miscellaneous) (Q3)"
369;24097;Journal of the Indian Chemical Society;journal;00194522;0.24;Q4;31;218;787;5087;250;781;0.3;23.33;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
370;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.239;Q3;35;77;165;1866;101;164;0.69;24.23;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q3)
371;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;0.237;Q3;25;30;11;627;14;8;1.75;20.90;United States;Springer USA;2006-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
372;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.237;Q4;25;24;53;2294;43;53;0.81;95.58;United Arab Emirates;Bentham Science Publishers;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4)"
373;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.237;Q3;34;41;41;1201;14;41;0.21;29.29;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
374;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.235;Q3;30;26;56;2055;37;52;0.71;79.04;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
375;25171;Mycotoxin Research;journal;01787888;0.234;Q3;31;24;142;570;85;131;0.96;23.75;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q3); Toxicology (Q3); Microbiology (Q4)"
376;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.233;Q3;25;1;88;0;53;83;0.48;0.00;United States;The Haworth Herbal Press;2001-2007;"Pharmacology (Q3); Biochemistry (Q4)"
377;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.233;Q3;17;10;59;192;38;50;0.82;19.20;United Kingdom;Librapharm Ltd.;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
378;22854;Yakugaku Zasshi;journal;00316903;0.233;Q3;37;208;473;5106;266;461;0.57;24.55;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
379;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0.223;Q3;33;46;105;1070;48;105;0.47;23.26;United Kingdom;BioMed Central;2000-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
380;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0.223;Q2;14;28;83;909;29;71;0.32;32.46;Hungary;Neuroline;2004-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q3); Neuroscience (miscellaneous) (Q4)"
381;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0.223;Q3;23;65;146;1722;37;146;0.15;26.49;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
382;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.223;Q3;9;33;108;374;16;108;0.21;11.33;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q3)
383;144613;Journal of Generic Medicines;journal;17411343;0.22;Q3;14;42;130;451;26;114;0.22;10.74;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
384;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.22;Q4;9;28;88;631;22;87;0.19;22.54;Japan;Medical and Pharmaceutical Society for WAKAN-YAKU;2004, 2006-2007;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
385;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.218;Q3;25;37;97;1138;46;97;0.43;30.76;United States;Begell House;2005-ongoing;"Applied Microbiology and Biotechnology (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
386;22906;Journal of China Pharmaceutical University;journal;10005048;0.217;Q3;13;97;337;1140;80;337;0.21;11.75;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
387;15842;Journal of Applied Research;journal;1537064X;0.215;Q3;18;24;137;822;54;127;0.27;34.25;United States;Therapeutic Solutions LLC;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
388;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.215;Q3;35;97;177;3410;99;168;0.59;35.15;United Kingdom;Taylor & Francis;1991-ongoing;"Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
389;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0.213;Q3;15;42;133;1101;27;132;0.26;26.21;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q3)
390;22908;Chinese Pharmacological Bulletin;journal;10011978;0.212;Q3;15;395;1071;5746;606;1071;0.75;14.55;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q3)
391;79053;Natural Product Sciences;journal;12263907;0.212;Q4;22;44;150;895;52;150;0.31;20.34;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
392;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.211;Q3;22;61;95;1691;35;88;0.4;27.72;United Kingdom;BioMed Central;2006-ongoing;"Infectious Diseases (Q3); Toxicology (Q3); Animal Science and Zoology (Q4); Parasitology (Q4)"
393;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.208;Q4;22;38;200;2432;73;174;0.39;64.00;Netherlands;Elsevier BV;2004-2014;"Drug Discovery (Q4); Molecular Medicine (Q4)"
394;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.208;Q3;19;24;55;627;17;55;0.31;26.13;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
395;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.205;Q3;45;60;200;1627;102;162;0.55;27.12;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
396;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.204;Q2;11;0;7;0;3;6;0.5;0.00;United States;JAI Press;1996, 1999, 2003, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Infectious Diseases (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
397;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.204;Q3;26;21;71;917;49;68;0.73;43.67;Spain;Elsevier Espana;2005-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
398;35190;Revista Espanola de Quimioterapia;journal;02143429;0.204;Q3;23;41;151;1635;83;138;0.66;39.88;Spain;Sociedad Espaola de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
399;21795;Farmaceuticky Obzor;journal;00148172;0.202;Q3;7;31;104;486;15;104;0.14;15.68;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q3)
400;21811;Farmacia Hospitalaria;journal;11306343;0.202;Q3;21;72;241;1301;88;136;0.64;18.07;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
401;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.201;Q3;32;83;191;2903;94;179;0.38;34.98;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
402;5800173401;Current Bioactive Compounds;journal;15734072;0.201;Q3;21;25;17;1887;13;16;0.81;75.48;United Arab Emirates;Bentham Science Publishers;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
403;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.201;Q3;9;154;192;1075;25;171;0.15;6.98;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Pharmacology (nursing) (Q2); Pharmacy (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
404;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.201;Q3;15;47;156;730;21;135;0.21;15.53;United States;SAGE Publications Inc.;2000-ongoing;"Marketing (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q3)"
405;73430;Pharmaceutical Technology;journal;15432521;0.201;Q3;35;205;583;1047;105;393;0.24;5.11;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q3); Biophysics (Q4)"
406;20684;Current Pharmacogenomics;journal;15701603;0.2;Q3;11;0;77;0;36;77;0.36;0.00;United Arab Emirates;Bentham Science Publishers;2004-2007;"Pharmacology (Q3); Genetics (Q4)"
407;144963;Drug Discovery Today: Disease Models;journal;17406757;0.197;Q4;23;39;146;2088;61;131;0.55;53.54;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q4); Molecular Medicine (Q4)"
408;22357;IDrugs : the investigational drugs journal;journal;13697056;0.196;Q3;32;153;540;988;198;529;0.37;6.46;United Kingdom;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
409;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.194;Q4;32;50;96;2741;45;93;0.43;54.82;United States;Taylor and Francis;2004-ongoing;"Immunology (Q4); Toxicology (Q4)"
410;13718;Pharmaceutical Engineering;journal;02738139;0.194;Q3;13;34;172;208;24;151;0.17;6.12;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q3)
411;5200152843;Farmaceutico Hospitales;journal;02144697;0.192;Q3;3;15;53;147;4;41;0.1;9.80;Spain;Ediciones Mayo;2006-2009;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
412;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.192;Q3;17;231;689;1197;38;665;0.05;5.18;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
413;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.19;Q4;8;26;58;400;8;58;0.18;15.38;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
414;11100153314;Frontiers in Medicinal Chemistry;book series;15740889;0.189;Q4;6;0;27;0;6;26;0.23;0.00;United Arab Emirates;Bentham Science Publishers;2006, 2009-2010;"Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
415;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.189;Q3;14;40;141;4230;50;124;0.31;105.75;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
416;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.188;Q3;5;40;121;188;7;118;0.09;4.70;United States;Russell Publishing LLC;2010-ongoing;"Health Policy (Q3); Pharmaceutical Science (Q3)"
417;21227;Pharmacy in Practice;journal;13581538;0.188;Q3;5;53;189;711;19;161;0.15;13.42;United Kingdom;Medicom Publishing;1995-2009;"Pharmacy (Q2); Health Policy (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
418;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.188;Q3;8;25;111;472;8;105;0.06;18.88;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacy (Q3)"
419;22934;Chinese Pharmaceutical Journal;journal;10012494;0.187;Q3;19;506;1393;5344;273;1393;0.19;10.56;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
420;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.185;Q3;32;19;35;1084;24;34;0.73;57.05;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
421;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.184;Q3;35;120;265;2495;102;259;0.46;20.79;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
422;73076;Drug Discovery World;journal;14694344;0.184;Q4;10;27;105;245;27;95;0.34;9.07;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
423;130007;Drug Design Reviews Online;journal;15672697;0.183;Q3;10;0;48;0;21;48;0;0.00;United Arab Emirates;Bentham Science Publishers;2005;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
424;19446;American Pharmaceutical Review;journal;10998012;0.181;Q3;20;97;312;1551;88;305;0.26;15.99;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q3)
425;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0.181;Q3;9;27;86;1029;21;86;0.27;38.11;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Clinical Psychology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
426;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.179;Q4;25;34;83;722;41;80;0.62;21.24;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
427;144879;Toxicology International;journal;09716580;0.178;Q4;21;17;66;421;10;65;0.13;24.76;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
428;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.175;Q3;26;621;1431;7325;390;1431;0.23;11.80;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
429;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.174;Q3;43;118;169;6660;93;158;0.59;56.44;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Chemical Health and Safety (Q2); Safety Research (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
430;130089;Toxin Reviews;journal;15569543, 15569551;0.174;Q4;38;19;70;1383;23;63;0.43;72.79;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q4)
431;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.173;Q4;26;22;129;603;60;129;0.29;27.41;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
432;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.172;Q3;9;21;95;210;14;92;0.28;10.00;Netherlands;IOS Press;2010-ongoing;"Health Policy (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
433;130006;Medicinal Chemistry Reviews - Online;journal;15672034;0.171;Q4;6;0;46;0;18;46;0;0.00;United Arab Emirates;Bentham Science Publishers;2005;"Drug Discovery (Q4); Molecular Medicine (Q4)"
434;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.17;Q3;19;29;140;2656;28;125;0.27;91.59;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
435;24071;Metal-Based Drugs;journal;07930291, 16875486;0.168;Q3;33;16;5;929;6;4;1.5;58.06;Egypt;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Pharmacology (Q3); Drug Discovery (Q4); Inorganic Chemistry (Q4); Toxicology (Q4)"
436;21412;Zeitschrift fr Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.168;Q3;12;63;185;533;16;117;0.18;8.46;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
437;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.166;Q3;22;22;130;406;40;130;0.09;18.45;United States;Western Pharmacology Society, Inc.;1960-1969, 1973-2011;Pharmacology (Q3)
438;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.165;Q4;8;15;17;951;4;14;0;63.40;United States;Elsevier Inc.;2004-2005, 2008, 2012-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
439;25253;Blutalkohol;journal;00065250;0.164;Q4;13;32;82;321;9;76;0.13;10.03;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
440;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.164;Q3;17;16;35;677;10;32;0.33;42.31;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Sports Science (Q4)"
441;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.163;Q3;21;0;193;0;67;193;0.33;0.00;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
442;22514;Japanese Journal of Chemotherapy;journal;13407007;0.163;Q3;12;44;168;682;60;168;0.21;15.50;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
443;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;0.16;Q4;36;23;107;716;36;105;0.34;31.13;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine (Q3); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
444;18384;Medicinal Chemistry Research;journal;10542523;0.16;Q3;38;56;246;1269;40;246;0.13;22.66;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
445;9800153137;Trastornos Adictivos;journal;15750973;0.16;Q3;8;26;32;908;11;22;0.5;34.92;Spain;Elsevier Doyma;2007-2012;"Pharmacology (Q3); Psychiatry and Mental Health (Q3)"
446;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.156;Q3;22;38;151;1080;63;146;0.52;28.42;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
447;130031;Journal of Toxicologic Pathology;journal;09149198;0.156;Q4;20;39;78;2271;21;78;0.33;58.23;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
448;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.156;Q4;11;16;49;31;14;49;0.26;1.94;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
449;21127;Pharmaceutical Technology Europe;journal;17537967;0.155;Q3;16;97;327;650;50;208;0.16;6.70;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q3)
450;11200153563;Drug Metabolism Letters;journal;18723128;0.154;Q3;23;45;52;1282;21;51;0.41;28.49;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Biochemistry (medical) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4)"
451;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.153;Q3;7;24;40;710;10;33;0.18;29.58;United States;Haworth Press Inc.;2003-2008;"Health Policy (Q3); Pharmaceutical Science (Q3); Pharmacology (Q4)"
452;21142;Pharmaceutisch Weekblad;journal;00316911;0.153;Q4;9;346;1597;416;13;933;0.01;1.20;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
453;4100151616;Supportive Cancer Therapy;journal;15432912;0.153;Q4;13;0;66;0;18;55;0.33;0.00;United States;Cancer Information Group;2006-2007;"Oncology (Q3); Cancer Research (Q4); Pharmacology (Q4)"
454;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.15;Q3;14;36;117;1078;22;117;0.2;29.94;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q3)
455;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0.149;Q4;34;36;123;1012;45;117;0.24;28.11;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
456;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;0.149;Q4;29;70;205;2212;54;205;0.26;31.60;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology (Q4)
457;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0.148;Q3;7;0;14;0;7;12;0;0.00;United Kingdom;Elsevier Science;1996, 2000, 2003, 2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4)"
458;19600162009;Advances in Molecular Toxicology;book series;18720854;0.146;Q4;10;8;6;1048;1;5;0.2;131.00;Netherlands;Elsevier BV;2006, 2008-ongoing;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
459;5800173386;Current Drug Safety;journal;15748863;0.146;Q4;31;36;65;1701;24;63;0.38;47.25;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4); Toxicology (Q4)"
460;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0.145;Q4;13;155;337;2645;28;336;0.09;17.06;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
461;145693;Canadian Pharmacists Journal;journal;17151635;0.145;Q3;18;80;422;556;22;229;0.11;6.95;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
462;4000151610;International Journal of Neuroprotection and Neurogeneration;journal;17451183, 17451191;0.145;Q4;5;11;44;581;12;39;0.31;52.82;United Kingdom;RPA Publishers.;2006-2008;"Neurology (clinical) (Q4); Pharmacology (Q4)"
463;23171;Korean Journal of Pharmacognosy;journal;02533073;0.145;Q3;14;62;184;1364;36;184;0.18;22.00;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
464;22977;Journal de Pharmacie de Belgique;journal;00472166;0.144;Q3;12;24;60;345;12;56;0.16;14.38;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
465;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.144;Q4;16;35;100;846;24;100;0.18;24.17;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q4)
466;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.143;Q4;23;85;69;2874;7;67;0.1;33.81;United States;Current Medicine Group;2007-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
467;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X;0.142;Q4;21;21;28;1479;10;28;0.36;70.43;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Immunology and Allergy (Q4)"
468;22205;Saudi Pharmaceutical Journal;journal;13190164;0.142;Q3;36;31;78;1077;8;78;0.09;34.74;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
469;19700174893;Dhaka University Journal of Pharmaceutical Sciences;journal;18161839, 18161820;0.141;Q3;10;32;26;488;4;26;0.15;15.25;Bangladesh;University of Dhaka;2007-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
470;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0.141;Q4;15;40;136;1355;36;123;0.38;33.88;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
471;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;0.14;Q4;41;56;86;179;26;74;0.35;3.20;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
472;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.14;Q4;5;20;32;412;4;32;0.21;20.60;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Dentistry (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
473;21800;Farmacevtski Vestnik;journal;00148229;0.139;Q4;4;51;87;1265;3;86;0.03;24.80;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4)"
474;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;book series;18715125;0.139;Q3;15;8;29;687;5;24;0;85.88;United States;Elsevier Inc.;2001-2003, 2005, 2007-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
475;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.138;Q4;15;11;57;191;5;57;0.09;17.36;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q4)
476;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0.138;Q4;23;52;131;1634;16;129;0.14;31.42;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q4); Physiology (Q4)"
477;21716;Pharmazeutische Zeitung;journal;00317136;0.138;Q4;7;437;1286;909;10;538;0.02;2.08;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
478;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0.136;Q4;25;138;309;1769;10;211;0.04;12.82;India;Medknow Publications;1996-1999, 2002-ongoing;"Anesthesiology and Pain Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
479;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.136;Q4;24;48;59;1358;16;59;0.3;28.29;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
480;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.135;Q4;13;72;295;1414;40;295;0.15;19.64;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q4); Toxicology (Q4)"
481;5800179590;Pharmacologyonline;journal;18278620;0.135;Q4;21;222;136;5122;30;136;0.22;23.07;Italy;SILAE;2007-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
482;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0.134;Q4;8;16;116;721;12;113;0.08;45.06;Spain;Real Academia Nacional de Farmacia;2004-2005;"Pharmacology (medical) (Q3); Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4)"
483;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.134;Q4;11;80;238;1497;39;238;0.19;18.71;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
484;80593;Journal of Medicinal Plants;journal;16840240;0.134;Q4;16;50;142;1188;20;142;0.14;23.76;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
485;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;0.134;Q4;12;26;199;510;42;197;0.21;19.62;Germany;Springer Verlag;2006-2008;"Biotechnology (Q4); Chemistry (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
486;20572;PZ Prisma;journal;09455566;0.133;Q4;5;25;85;502;3;75;0.02;20.08;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
487;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.132;Q4;14;16;31;522;7;31;0.19;32.63;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmacology (medical) (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
488;21798;Farmaceutski Glasnik;journal;00148202;0.131;Q4;5;79;48;379;6;48;0.15;4.80;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
489;58808;Pharmaceutical Care and Research;journal;16712838;0.131;Q4;7;123;312;946;11;312;0.02;7.69;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
490;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.131;Q4;37;0;32;0;7;32;0.39;0.00;United States;PJD Publications Ltd.;1994-2007, 2009;"Medicine (miscellaneous) (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
491;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.13;Q4;26;170;478;2653;71;477;0.13;15.61;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
492;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.13;Q4;11;19;31;428;4;30;0.13;22.53;Turkey;Turkish Pharmacists Association;2006-ongoing;"Molecular Medicine (Q4); Pharmaceutical Science (Q4)"
493;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.129;Q4;13;317;524;4230;66;524;0.13;13.34;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
494;22338;Hospital Pharmacy;journal;00185787;0.128;Q4;21;145;397;1841;46;353;0.16;12.70;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacy (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
495;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.128;Q4;13;122;215;1886;21;215;0.12;15.46;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
496;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0.126;Q4;18;44;61;616;4;60;0.07;14.00;India;Aall India Institute of Medical Sciences;2008-ongoing;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
497;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.125;Q4;12;78;214;952;22;164;0.15;12.21;United Kingdom;John Wiley & Sons Ltd.;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
498;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.125;Q4;11;18;55;274;2;49;0.03;15.22;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
499;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.124;Q4;18;31;70;965;16;70;0.23;31.13;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology (Q4)
500;19399;Acta Pharmaceutica Hungarica;journal;00016659;0.123;Q4;12;18;77;430;5;77;0.04;23.89;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q4)"
501;16893;Biogenic Amines;journal;15693910, 01688561;0.123;Q4;14;0;75;0;15;74;0.08;0.00;Netherlands;V S P;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
502;130170;Phytotherapie;journal;17652847, 16248597;0.121;Q4;12;58;163;1117;10;108;0.08;19.26;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
503;4000151703;Core Evidence;journal;15551741, 1555175X;0.12;Q4;19;18;30;1192;2;29;0;66.22;United States;Core Medical Pub;2005-ongoing;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
504;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.12;Q4;5;14;15;444;4;13;0.31;31.71;Switzerland;Springer International Publishing AG;2007-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
505;17716;Quality Assurance Journal;journal;10991786, 10878378;0.12;Q4;7;0;87;0;5;73;0.09;0.00;United States;John Wiley & Sons Inc.;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
506;13000154717;Current Topics in Toxicology;journal;09728228;0.119;Q4;6;4;7;166;2;7;0.29;41.50;India;Research Trends;2007-2009, 2011-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
507;3300147901;EMC - Toxicologie-Pathologie;journal;17625858;0.119;Q4;5;0;14;0;5;14;0;0.00;France;Editions scientifique et medicales Elsevier SAS;2004-2005;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
508;22979;Journal of Applied Therapeutic Research;journal;10292659;0.119;Q4;7;12;19;205;5;19;0.33;17.08;United Kingdom;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
509;23107;Journal of Pharmacy Technology;journal;87551225;0.119;Q4;9;27;115;731;12;102;0.11;27.07;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q4)
510;25196;Revista Brasileira de Toxicologia;journal;14152983;0.119;Q4;6;13;33;421;4;32;0;32.38;Brazil;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
511;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.117;Q4;4;40;130;757;5;130;0.06;18.93;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
512;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.115;Q4;9;26;56;1093;3;56;0.06;42.04;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
513;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.114;Q4;2;29;95;206;3;79;0.02;7.10;Netherlands;Elsevier BV;2005-2012;Pharmaceutical Science (Q4)
514;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0.114;Q4;10;27;32;794;6;32;0.19;29.41;France;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
515;21100301409;Issues in Toxicology;book series;17577179;0.114;Q4;12;25;26;3368;2;24;0.08;134.72;United Kingdom;Royal Society of Chemistry;2007-ongoing;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
516;22358;U.S. Pharmacist;journal;01484818;0.114;Q4;7;161;171;2759;15;161;0.09;17.14;United States;Jobson Publishing LLC;1979, 1990-1996, 2007-ongoing;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
517;19430;Adverse Drug Reaction Bulletin;journal;00446394;0.113;Q4;7;6;16;177;3;16;0.2;29.50;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
518;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.112;Q4;5;77;262;489;3;254;0.01;6.35;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
519;21083;Pharmaceutical Care Espana;journal;11396202;0.112;Q4;9;28;79;477;3;62;0.07;17.04;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
520;86688;Acta Toxicologica;journal;17316383;0.111;Q4;7;0;53;0;11;48;0.29;0.00;Poland;Instytut Medycyny Pracy im. Jerzego Nofera/Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
521;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.111;Q4;9;54;124;739;7;123;0.05;13.69;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
522;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.111;Q4;3;26;43;368;1;41;0.03;14.15;Belgium;Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
523;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.111;Q4;11;0;2;0;0;2;0;0.00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
524;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.111;Q4;14;0;2;0;0;2;0;0.00;India;A and V Publication;2011-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
525;25197;Revista de Toxicologia;journal;16970748, 02127113;0.111;Q4;9;12;55;444;6;55;0.09;37.00;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
526;19408;Actualites Pharmaceutiques;journal;05153700;0.11;Q4;5;190;506;130;2;391;0;0.68;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
527;19700180757;Advances in Phytomedicine;book series;1572557X;0.11;Q4;12;0;43;0;5;39;0.13;0.00;Netherlands;Elsevier BV;2002, 2006;"Drug Discovery (Q4); Plant Science (Q4)"
528;20628;Circular Farmaceutica;journal;00097314;0.11;Q4;2;41;126;350;2;109;0;8.54;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
529;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.11;Q4;3;44;267;136;0;258;0;3.09;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
530;22887;Chinese Journal of Antibiotics;journal;10018689;0.109;Q4;10;189;536;2171;21;529;0.03;11.49;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
531;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.109;Q4;6;38;72;174;2;68;0.03;4.58;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2007-2010, 2012-ongoing;Pharmaceutical Science (Q4)
532;5400152620;American Journal of Pharmacology and Toxicology;journal;15574970, 15574962;0.108;Q4;16;24;21;1243;3;21;0.14;51.79;United States;Science Publications;2007-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
533;19700175108;Drug Delivery System;journal;09135006;0.108;Q4;7;28;109;604;9;109;0.13;21.57;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
534;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.108;Q4;17;130;379;2484;23;370;0.06;19.11;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
535;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.108;Q4;7;12;25;156;2;25;0;13.00;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
536;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0.107;Q4;7;0;24;0;2;24;0.14;0.00;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
537;19700175819;Patient Preference and Adherence;journal;1177889X;0.107;Q4;37;50;19;1598;3;19;0.16;31.96;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Health Policy (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Social Sciences (miscellaneous) (Q4)"
538;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.106;Q4;8;33;87;911;7;66;0.11;27.61;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
539;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.104;Q4;2;14;5;0;0;5;0;0.00;Japan;Research Laboratory of Shionogi and Co.;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
540;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.104;Q4;4;94;105;1305;4;105;0.04;13.88;China;China Pharmaceutical University;2007-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
541;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0.104;Q4;18;22;54;263;6;54;0.13;11.95;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
542;11800154521;ICBPE 2006 - Proceedings of the 2006 International Conference on Biomedical and Pharmaceutical Engineering;conference and proceedings;00002006;0.104;-;8;0;124;0;5;123;0.04;0.00;United States;;2006;"Biomedical Engineering; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
543;21077;Pharmaca;journal;00316857;0.104;Q4;4;18;38;153;1;36;0;8.50;Croatia;Association of Croatian Health Organizations;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
544;5800207507;Side Effects of Drugs Annual;book series;03786080;0.103;Q4;5;52;101;3058;3;52;0;58.81;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
545;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.102;Q4;6;37;128;237;3;128;0.02;6.41;Spain;Real Academia Nacional de Medicina;1949-2011;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
546;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.102;Q4;9;0;10;0;0;9;0;0.00;Singapore;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
547;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.102;Q4;14;24;75;893;1;72;0;37.21;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q4)
548;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0.102;Q4;7;95;130;733;5;128;0.05;7.72;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
549;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.102;Q4;5;0;9;0;1;9;0.11;0.00;Nigeria;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009;Pharmacology (Q4)
550;130150;Advances in Pharmacy;journal;15323862;0.101;Q4;1;0;25;0;0;16;0;0.00;United States;Facts and Comparisons;2005;Pharmaceutical Science (Q4)
551;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0.101;Q4;9;10;26;61;2;18;0;6.10;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
552;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.101;Q4;4;18;26;665;0;24;0;36.94;Venezuela;Tribuna Medica Venezolana;2007-2013, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
553;9100153105;Current Topics in Pharmacology;journal;09724559;0.101;Q4;4;16;36;1219;1;36;0.03;76.19;India;Research Trends;2006-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
554;4700152278;Drugs in Context;journal;17404398, 17451981;0.101;Q4;12;20;55;710;1;41;0.02;35.50;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (Q4)"
555;144718;Enhancer - Biotherapy of Cancer;journal;15720004;0.101;Q4;0;0;43;0;0;21;0;0.00;United States;Duke University Press;2005-2006;"Cancer Research (Q4); Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Oncology (Q4)"
556;21867;Geneesmiddelenbulletin;journal;03044629;0.101;Q4;6;57;193;203;3;31;0.11;3.56;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
557;17700156431;Handbook of Analytical Separations;book series;15677192;0.101;Q4;11;0;32;0;0;0;0;0.00;Netherlands;Elsevier BV;2000-2001, 2003-2004, 2007;"Analytical Chemistry (Q4); Environmental Chemistry (Q4); Pathology and Forensic Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
558;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.101;Q4;8;0;16;0;0;16;0;0.00;India;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007;Pharmacology (Q4)
559;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.101;Q4;8;12;31;155;0;29;0;12.92;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
560;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.101;Q4;5;234;802;2324;19;802;0.03;9.93;China;Jilin University;2005-ongoing;Pharmacology (Q4)
561;21243;Pharmacy times;trade journal;00030627;0.101;Q4;8;189;244;378;9;212;0.04;2.00;United States;Romaine Pierson Publishers;1947-1949, 1975, 1977-1987, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
562;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.101;Q4;2;7;40;121;0;29;0;17.29;Germany;Wissenschaftliche Verlagsgesellschaft;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
563;145000;Signal;journal;14719967;0.101;Q4;1;0;34;0;1;20;0;0.00;United Kingdom;Adis International Ltd.;2005-2007;"Drug Discovery (Q4); Oncology (Q4); Pharmacology (medical) (Q4)"
564;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;0.101;Q4;5;0;25;0;0;25;0;0.00;Taiwan;Pharmaceutical Society of Taiwan;2007, 2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
565;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0.101;Q4;12;55;57;900;1;55;0;16.36;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
566;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.1;Q4;6;0;52;0;1;42;0;0.00;Spain;Alpe Editores;1996-2007;Pharmacology (Q4)
567;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.1;Q4;22;21;49;531;4;49;0;25.29;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
568;21238;Drug Topics;journal;00126616;0.1;Q4;7;305;1294;0;5;1023;0;0.00;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
569;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.1;Q4;2;69;116;43;0;105;0;0.62;Germany;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
570;21823;Farmatsija;journal;04280296;0.1;Q4;5;12;83;161;2;83;0.04;13.42;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
571;15680;Giornale di Neuropsicofarmacologia;journal;03919048;0.1;Q4;1;18;54;119;0;47;0;6.61;Italy;C I C Edizioni International srl;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
572;13637;Manufacturing Chemist;journal;02624230;0.1;Q4;6;74;79;143;0;68;0;1.93;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science (Q4)
573;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;295;366;24;0;131;0;0.08;Spain;Reed Business Information Ltd;2006-2011;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
574;5200152604;Pharma Times;journal;00316849;0.1;Q4;10;62;96;282;1;70;0.01;4.55;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
575;72755;Phytomedica;journal;09723293;0.1;Q4;4;14;49;108;0;49;0;7.71;India;Scientific Publishers;1999-2006;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
576;12100156823;5th PCIC Europe 2008: Petroleum and Chemical Industry Conference Europe;conference and proceedings;00002008;;-;5;29;0;185;0;0;0;6.38;United States;;2008;"Chemical Engineering (miscellaneous); Electrical and Electronic Engineering; Geochemistry and Petrology; Pharmaceutical Science"
577;19700175149;African Journal Biomedical Research;journal;11195096;;-;15;48;0;995;0;0;0;20.73;Nigeria;Bioline International;2008, 2010-ongoing;"Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
578;19700174969;Archives of Drug Information;journal;17535174;;-;10;14;0;368;0;0;0;26.29;United States;John Wiley & Sons Inc.;2008-2011;"Complementary and Alternative Medicine; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
579;19700174886;Arzneimitteltherapie;journal;07236913;;-;6;162;0;1153;0;0;0;7.12;Germany;Wissenschaftliche Verlagsgesellschaft;2008-ongoing;"Pharmacology (medical); Pharmacology (nursing); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
580;10900153302;Biomarker Insights;journal;11772719;;-;24;33;0;2028;0;0;0;61.45;New Zealand;Libertas Academica;2008-ongoing;"Biochemistry (medical); Molecular Medicine; Pharmacology"
581;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;;-;37;42;0;2682;0;0;0;63.86;United Kingdom;Future Medicine Ltd.;2008-ongoing;"Biochemistry (medical); Clinical Biochemistry; Drug Discovery"
582;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;;-;26;65;0;1800;0;0;0;27.69;South Korea;Korean Society of Applied Pharmacology;2008-ongoing;"Biochemistry; Drug Discovery; Molecular Medicine; Pharmacology"
583;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;;-;16;40;0;1635;0;0;0;40.88;Chile;Universidad de Santiago de Chile;2008-ongoing;"Complementary and Alternative Medicine; Drug Discovery; Pharmacology; Plant Science"
584;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;;-;7;26;0;700;0;0;0;26.92;Egypt;Faculty of Pharmacy, Assiut University;2008-2013;"Pharmaceutical Science; Pharmacology"
585;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;;-;39;34;0;1924;0;0;0;56.59;United States;Wiley-Blackwell;2008-ongoing;"Cardiology and Cardiovascular Medicine; Medicine (miscellaneous); Pharmacology; Pharmacology (medical)"
586;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;;-;3;129;0;2495;0;0;0;19.34;China;Chinese Journal of Cancer Biotheraphy;2008-ongoing;"Cancer Research; Molecular Medicine; Pharmacology"
587;19700174922;Chinese Journal of New Drugs;journal;10033734;;-;9;565;0;6700;0;0;0;11.86;China;Chinese Journal of New Drugs Co. Ltd.;2008-ongoing;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
588;19700174918;Clinical and Translational Science;journal;17528062, 17528054;;-;35;61;0;1509;0;0;0;24.74;United States;Wiley-Blackwell;2008-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Neuroscience (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
589;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;;-;59;28;0;2007;0;0;0;71.68;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology; Pharmacology (medical); Physiology (medical); Psychiatry and Mental Health"
590;19600166302;Current molecular pharmacology;journal;18744702;;-;34;23;0;2979;0;0;0;129.52;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Drug Discovery; Molecular Medicine; Pharmacology"
591;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;;-;17;25;0;2760;0;0;0;110.40;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Genetics; Genetics (clinical); Molecular Biology; Molecular Medicine; Pharmacology"
592;19300156901;Dose-Response;journal;15593258;;-;30;21;0;1262;0;0;0;60.10;United States;International Dose-Response Society;2008-ongoing;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Public Health, Environmental and Occupational Health; Toxicology"
593;19700175230;Drug Design, Development and Therapy;journal;11778881;;-;48;29;1;1680;0;0;0;57.93;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Drug Discovery; Pharmaceutical Science; Pharmacology"
594;19700174889;Drug Target Insights;journal;11773928;;-;10;14;0;736;0;0;0;52.57;New Zealand;Libertas Academica;2008-ongoing;"Clinical Biochemistry; Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
595;19200156912;EJHP Practice;journal;20303769, 17819989;;-;5;25;0;126;0;0;0;5.04;Belgium;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
596;19700174992;European Journal of Oncology Pharmacy;journal;20327072, 17833914;;-;3;17;0;77;0;0;0;4.53;Belgium;Pharma Publishing and Media Europe;2008-ongoing;"Oncology; Pharmacology"
597;10300153301;Expert Review of Clinical Pharmacology;journal;17512433;;-;32;58;0;4186;0;0;0;72.17;United Kingdom;Taylor & Francis;2008-ongoing;"Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
598;21810;Farmacia;journal;00148237;;-;19;84;0;938;0;0;0;11.17;Romania;Uniunea Societatilor De Stiinte Medicale;1973-1987, 2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
599;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;;-;60;174;0;5865;0;0;0;33.71;United States;Taylor and Francis;2008-ongoing;"Chemistry (miscellaneous); Food Science; Health, Toxicology and Mutagenesis; Medicine (miscellaneous); Public Health, Environmental and Occupational Health; Toxicology"
600;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;;-;21;22;0;622;0;0;0;28.27;United Kingdom;Taylor & Francis;2008-ongoing;"Food Science; Public Health, Environmental and Occupational Health; Toxicology"
601;11200153304;Future HIV Therapy;journal;17469600;;-;8;57;0;3017;0;0;0;52.93;United Kingdom;Future Medicine Ltd.;2008-2009;"Drug Discovery; Infectious Diseases; Pharmacology; Pharmacology (medical); Virology"
602;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;;-;6;12;0;559;0;0;0;46.58;Turkey;Hacettepe Universitesi;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
603;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;;-;17;71;0;1197;0;0;0;16.86;India;Association of Pharmaceutical Teachers of India;2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
604;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;;-;23;26;0;757;0;0;0;29.12;Slovakia;Slovak Toxicology Society SETOX;2010-ongoing;"Health, Toxicology and Mutagenesis; Pharmacology; Toxicology"
605;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;;-;12;30;0;683;0;0;0;22.77;United Kingdom;Inderscience Enterprises;2008-ongoing;"Computer Science Applications; Drug Discovery"
606;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;;-;31;44;0;1028;0;0;0;23.36;Iran;Shaheed Behesti University of Medical Sciences and Health;2008-ongoing;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
607;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;;-;44;62;0;1486;0;0;0;23.97;United States;Springer New York LLC;2008-ongoing;"Cardiology and Cardiovascular Medicine; Genetics; Genetics (clinical); Molecular Medicine; Pharmaceutical Science"
608;11200153306;Journal of Pharmacology and Toxicology;journal;1816496X;;-;15;48;0;1101;0;0;0;22.94;United States;Academic Journals Inc.;2008-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
609;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;17;122;138;3268;23;138;0.17;26.79;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-ongoing;"Drug Discovery; Pharmaceutical Science"
610;19700182629;Methods in Pharmacology and Toxicology;book series;15572153;;-;6;22;0;1742;0;0;0;79.18;United States;Humana Press, Inc.;2008, 2012-ongoing;"Molecular Medicine; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
611;11900154394;Oriental Journal of Chemistry;journal;0970020X, 22315039;;-;18;187;0;3032;0;0;0;16.21;India;Scientific Publishers;2008-ongoing;"Biochemistry; Chemistry (miscellaneous); Drug Discovery; Environmental Chemistry"
612;19700174891;Perspectives in Medicinal Chemistry;journal;1177391X;;-;13;7;0;666;0;0;0;95.14;New Zealand;Libertas Academica;2008-2011, 2014-ongoing;"Drug Discovery; Pharmaceutical Science; Pharmacology; Pharmacology (medical)"
613;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;;-;2;11;0;131;0;0;0;11.91;Netherlands;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology; Pharmacology (medical)"
614;19200156706;Pharmacognosy Magazine;journal;09731296, 09764062;;-;29;75;0;1654;0;0;0;22.05;India;Medknow Publications;2008-ongoing;"Drug Discovery; Pharmaceutical Science"
615;19700174966;Pharmakeftiki;journal;11054999;;-;2;17;0;515;0;0;0;30.29;Greece;Papathanasopoulos;2008-ongoing;"Pharmaceutical Science; Pharmacology"
616;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;;-;18;128;0;2826;0;0;0;22.08;India;Rasayan Journal;2009-ongoing;"Biochemistry; Chemical Engineering (miscellaneous); Chemistry (miscellaneous); Energy (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
617;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148;;-;20;17;0;1775;0;0;0;104.41;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Biochemistry (medical); Drug Discovery; Endocrinology, Diabetes and Metabolism; Immunology and Allergy; Medicine (miscellaneous)"
618;19700175031;Research Journal of Pharmacology;journal;18159362, 19936109;;-;7;12;0;222;0;0;0;18.50;Pakistan;Medwell Online;2008-2016 (cancelled);"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
619;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;;-;40;19;0;1083;0;0;0;57.00;United Kingdom;SAGE Publications;2008-ongoing;"Neurology; Neurology (clinical); Pharmacology"
620;21100197929;Toxicological Research;journal;19768257;;-;20;42;0;1552;0;0;0;36.95;South Korea;Korean Association of Medical Journal Editors;2008-ongoing;"Health, Toxicology and Mutagenesis; Toxicology"
621;19700175137;Trends in Medical Research;journal;18193587;;-;8;11;0;373;0;0;0;33.91;United States;Academic Journals Inc.;2008-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
